risperidone has been researched along with Nocturnal Wandering in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, ML | 1 |
| Shen, WW | 1 |
| Meguro, K | 1 |
| Meguro, M | 1 |
| Tanaka, Y | 1 |
| Akanuma, K | 1 |
| Yamaguchi, K | 1 |
| Itoh, M | 1 |
1 trial available for risperidone and Nocturnal Wandering
| Article | Year |
|---|---|
Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Analysis of Variance; Antipsychotic Agents; | 2004 |
1 other study available for risperidone and Nocturnal Wandering
| Article | Year |
|---|---|
Sleep-related eating disorder induced by risperidone.
Topics: Aged; Antipsychotic Agents; Dementia, Vascular; Dose-Response Relationship, Drug; Humans; Hyperphagi | 2004 |